International Conference on

Advances in Clinical Oncology (IACO-27)

Conference Date

3rd May - 4th May 2027

Conference Venue

Toronto, Canada

Conference Mode

Hybrid Conference
Proudly organized by:- Science Leagues

"Join global experts in Advances in Clinical Oncology"

Registration Options →

View all registration categories and choose the best fit.

Conference Programme

Tentative Conference Agenda

Explore the proposed two-day programme developed around the conference Session Tracks and aligned United Nations Sustainable Development Goals.

Conference Format Hybrid Conference In-person and virtual participation
Programme 2 Days 3–4 May 2027
Academic Scope 11 Tracks Conference Session Tracks
Research Scope 20 Areas Call for Papers themes
SDG Alignment 4 SDGs SDGs 3, 4, 9 and 10
Tentative Agenda & Timings

Session timings, sequence, track grouping and allocations are tentative and subject to change. Final timings will be confirmed closer to the conference. All timings follow the local time of the conference location.

Day 01

Opening, Keynote & Technical Sessions

3 MAY 2027 HYBRID
  1. 09:00 AM 09:30 AM

    Registration, Welcome Kit Collection & Virtual Check-in

    Participant arrival, credential verification and virtual lobby access.

    HYBRID
  2. 09:30 AM 09:45 AM

    Networking Tea & Digital Welcome

    Informal networking for on-site and virtual participants.

    HYBRID
  3. 09:45 AM 10:30 AM

    Welcome Address, Opening Plenary & Keynote Presentation I

    Opening of the conference and introduction to its research focus.

    PLENARY
  4. 10:30 AM 12:30 PM

    Concurrent Technical Session I

    3 TRACKS
    Track 01
    Innovations in Cancer Treatment
    34
    Track Overview

    This track focuses on the latest advancements in cancer treatment modalities, including chemotherapy, radiotherapy, and surgical interventions. Participants will explore novel therapeutic approaches and their implications for patient outcomes.

    Track 02
    Translational Oncology: Bridging Research and Practice
    39
    Track Overview

    This session emphasizes the importance of translational research in oncology, highlighting how laboratory discoveries can be effectively applied to clinical settings. Discussions will include case studies that demonstrate successful translation of research findings into therapeutic strategies.

    Track 03
    Immunotherapy: Current Trends and Future Directions
    34
    Track Overview

    This track will delve into the evolving landscape of immunotherapy, examining the mechanisms of action and clinical applications of immune checkpoint inhibitors and CAR T-cell therapies. Experts will discuss challenges and opportunities in enhancing patient responses.

  5. 12:30 PM 01:30 PM

    Lunch & Networking Break

    Refreshment interval and networking opportunity.

    BREAK
  6. 01:30 PM 03:30 PM

    Concurrent Technical Session II

    3 TRACKS
    Track 04
    Precision Medicine in Oncology
    39
    Track Overview

    Focusing on the role of genomics and molecular profiling, this session will explore how precision medicine is transforming cancer treatment paradigms. Attendees will learn about personalized therapeutic strategies tailored to individual patient profiles.

    Track 05
    Tumor Biology: Mechanisms and Therapeutic Targets
    39
    Track Overview

    This track investigates the underlying biological mechanisms of tumor development and progression, with a focus on identifying novel therapeutic targets. Researchers will present findings that could lead to innovative treatment options.

    Track 06
    Patient Care and Quality of Life in Oncology
    310
    Track Overview

    This session addresses the critical aspects of patient care in oncology, including symptom management, psychosocial support, and survivorship issues. Discussions will highlight strategies to enhance the quality of life for cancer patients and their families.

  7. 03:30 PM 04:00 PM

    Interactive Q&A, Day 1 Summary & Group Photo

    Closing interaction and key takeaways from the first day.

    CLOSING
Day 02

Keynote, Technical Sessions & Awards

4 MAY 2027 HYBRID
  1. 09:00 AM 09:15 AM

    Participant Check-in & Day 2 Welcome

    On-site attendance confirmation and virtual lobby access.

    HYBRID
  2. 09:15 AM 10:00 AM

    Keynote Presentation II

    Expert address on the future of the conference research domain.

    PLENARY
  3. 10:00 AM 12:00 PM

    Concurrent Technical Session III

    3 TRACKS
    Track 07
    Health Policy and Cancer Care
    310
    Track Overview

    This track examines the intersection of health policy and oncology, focusing on the implications of policy decisions on cancer care delivery and access to treatment. Participants will engage in discussions about advocacy and the role of policy in shaping cancer research funding.

    Track 08
    Emerging Technologies in Oncology
    39
    Track Overview

    This session will explore the impact of emerging technologies, such as artificial intelligence and telemedicine, on cancer diagnosis and treatment. Experts will discuss how these innovations can improve patient outcomes and streamline clinical workflows.

    Track 09
    Clinical Trials and Research Methodology
    34
    Track Overview

    Focusing on the design and implementation of clinical trials in oncology, this track will cover best practices and innovative methodologies. Researchers will share insights on overcoming challenges in trial execution and patient recruitment.

  4. 12:00 PM 01:00 PM

    Lunch & Networking Break

    Refreshment interval and professional networking.

    BREAK
  5. 01:00 PM 03:00 PM

    Concurrent Technical Session IV

    2 TRACKS
    Track 10
    Pediatric Oncology: Unique Challenges and Advances
    310
    Track Overview

    This session will address the specific challenges faced in pediatric oncology, including treatment protocols and long-term effects of therapy. Experts will discuss recent advances in the field and the importance of tailored approaches for young patients.

    Track 11
    Global Perspectives in Cancer Research
    310
    Track Overview

    This track highlights international collaborations and research initiatives aimed at addressing cancer disparities worldwide. Participants will explore how global partnerships can enhance cancer research and improve outcomes in diverse populations.

  6. 03:00 PM 03:30 PM

    Publications, Best Paper & Best Presentation Awards

    Publication guidance and recognition of outstanding research contributions.

    AWARDS
  7. 03:30 PM 04:00 PM

    Valedictory Session, Closing Remarks & Group Photo

    Conference summary, acknowledgements and formal conclusion.

    CLOSING
Aligned SDGs
3 Good Health and Well-being 4 Quality Education 9 Industry, Innovation and Infrastructure 10 Reduced Inequalities

Be Part of IACO-27

Submit your research or complete your conference registration.